Home Health Care IBM brings AI into study of the progression of Parkinson’s disease

IBM brings AI into study of the progression of Parkinson’s disease

The Armonk-based company is expanding its AI modeling to the study of other diseases.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.